Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Mesenchymal stem cells: No longer second class marrow citizens

Nature Medicine volume 5, pages 262–264 (1999)Cite this article

Abstract

Osteogenesis Imperfeca study raises new hopes and questions for mesenchymal and stem cell therapies (pages 309–313).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Caplan, A.I. The mesengenic process. Clinics in Plastic Surgery 21, 429–435 (1994).

    CAS  PubMed  Google Scholar 

  2. Prockop, D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71–74 ( 1997).

    Article  CAS  Google Scholar 

  3. Horwitz, E.M. et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Med. 5, 309–313 ( 1999).

    Article  CAS  Google Scholar 

  4. Bruder, S.P., Jaiswal, N. & Haynesworth, S.E. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell. Biochem. 64 278–294 (1997).

    Article  CAS  Google Scholar 

  5. Majumdar, M.K., Thiede, M.A., Mosca, J.D., Moorman, M. & Gerson, S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell. Physiol. 176, 186– 192 (1998).

    Article  Google Scholar 

  6. Haynesworth, S., Baber, M. & Caplan, A. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13 , 69–80 (1992).

    Article  CAS  Google Scholar 

  7. Lazarus, H., Haynesworth, S., Gerson, S., Rosenthal, N. & Caplan, A. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Marrow Transplant 16, 557–564 ( 1995).

    CAS  PubMed  Google Scholar 

  8. Koç, O.N. et al. Rapid hematopoietic recovery after coinfusion of autologous culture-expanded human mesenchymal stem cells (hMSCs) and PBPCs in breast cancer patients receiving high-dose chemotherapy. Blood 92, 274a (1998).

    Google Scholar 

  9. Allay, J.A. et al. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Human Gene Therapy 8, 1417–1427 (1997).

    Article  CAS  Google Scholar 

  10. Ohgushi, H., Goldberg, V.M. & Caplan, A.I. Repair of bone defects with marrow cells and porous ceramic: Experiments in rats. Acta Orthopaedica Scandinavica 60, 334–339 (1989).

    Article  CAS  Google Scholar 

  11. Young, R.G. et al. The use of mesenchymal stem cells in Achilles tendon repair. Ortho. Res. 16, 406–413 (1998).

    Article  CAS  Google Scholar 

  12. Simmons, P.J., Przepiorka, D., Thomas, E.D. & Torok-Storb, B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328, 429–432 (1987).

    Article  CAS  Google Scholar 

  13. Marini, J.C. & Gerber, N.L. Osteogenesis imperfecta. JAMA 277, 746–750 ( 1997).

    Article  CAS  Google Scholar 

  14. Constantinou, C.D., Pack, M., Young, S.B. & Prockop, D.J. Phenotypic heterogeneity in osteogenesis imperfecta: The mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for αI-glycine 904 in a Type I procollagen gene (COLIAI). Am. J. Hum. Gen. 47, 670–679 (1990).

    CAS  Google Scholar 

  15. Pereira, R.F. et al.. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 95, 1142–1147 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology Ireland Cancer Center at Case Western Reserve University University Hospitals of Cleveland, Cleveland, 44106, Ohio, USA

    Stanton L. Gerson

Authors
  1. Stanton L. Gerson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerson, S. Mesenchymal stem cells: No longer second class marrow citizens. Nat Med 5, 262–264 (1999). https://doi.org/10.1038/6470

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/6470

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing